Narrative synthesis of published literature
Comparing Antidepressant Discontinuation Symptoms Across Drug Classes
How trazodone's withdrawal-type symptoms compare with those reported for SSRIs, SNRIs, and other antidepressant classes.
Published August 8, 2026. Reviewed by our editorial team on August 8, 2026.
Who was studied: Patients discontinuing various classes of antidepressants, based on published clinical literature
Antidepressant discontinuation symptoms are a well-recognized clinical phenomenon across drug classes, not something specific to trazodone. Symptoms like anxiety, irritability, sleep disruption, and flu-like feelings are described with SSRIs, SNRIs, tricyclics, and SARIs like trazodone alike, generally correlating with how abruptly the medication is stopped and how long/high-dose the prior use was.
Trazodone's own FDA labeling specifically names anxiety, agitation, and sleep problems as withdrawal symptoms. The clinical consensus across essentially every antidepressant class is the same: taper gradually under medical guidance rather than stopping abruptly, particularly after weeks or months of regular use.
Main result: Discontinuation symptoms — including anxiety, sleep disruption, and flu-like feelings — are described across essentially all antidepressant classes when stopped abruptly after regular use, including trazodone; the general clinical consensus favors gradual tapering regardless of which specific antidepressant is involved.
Limitations: Direct head-to-head comparisons of discontinuation severity between specific antidepressants (including trazodone) are less common than single-drug case reports and general clinical guidance, making precise cross-drug comparisons difficult to state with confidence.
Not medical advice. This summary is educational and does not replace individualized guidance from your prescriber.
